The isothermal nucleic acid amplification technology market was sized at USD 4,425.5 million in 2023, which will power at a rate of 9.4% by the end of this decade, to touch USD 8,159.4 million by 2030. This has a lot to do with the considerable rise in its use as a molecular testing method as a result of the increasing occurrence of communicable diseases.
TB, influenza, and hepatitis are amongst the main causes of death traceable to communicable ailments, particularly in developing nations.
Infectious diseases are a key reason for mortality and morbidity at a global level. This is why the snowballing incidence of communicable diseases is a key factor for the industry growth.
North America isothermal nucleic acid amplification technology market was the leader of the pack with around 45%, in 2023, and there will be a considerable growth in the years to come as well. This will be because of the recognized research infra and surge in the requirement for nucleic-acid-amplification-based diagnostics to for averting pandemics in the region.
The German market has a considerable share in Europe because of the rising elderly populace and considerable emphasis on the healthcare infra. As per the World Bank, the nation’s population, which was more than 65 years was around 19 million in 2021. These large elderly population will bring about a high prevalence of age-related ailments and communicable diseases. which would reinforce the market prospects for effective INAAT devices and reagents.
It is because of the changing lifestyles in developing countries of the world, the demand for isothermal nucleic acid amplification technology is on the rise. This trend will continue in the years to come as well.
